Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia.
about
Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytesRacial-ethnic disparities in management and outcomes among children with type 1 diabetes.Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals.Labile A1C is inversely correlated with the hemoglobin glycation index in children with type 1 diabetes.Racial disparity in A1C independent of mean blood glucose in children with type 1 diabetes.Estimated average glucose and self-monitored mean blood glucose are discordant estimates of glycemic controlValidation of a hemoglobin A1c model in patients with type 1 and type 2 diabetes and its use to go beyond the averaged relationship of hemoglobin A1c and mean glucose levelEvidence for consistency of the glycation gap in diabetes.Glucoregulatory function among African Americans and European Americans with normal or pre-diabetic hemoglobin A1c levels.The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trialDiabetes control and complications: the role of glycated haemoglobin, 25 years on.Implications of iron deficiency/anemia on the classification of diabetes using HbA1cSpuriously high prevalence of prediabetes diagnosed by HbA(1c) in young indians partly explained by hematological factors and iron deficiency anemia.Estimation of the glycation gap in diabetic patients with stable glycemic control.When the blood glucose and the HbA(1c) don't match: turning uncertainty into opportunity.Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention ProgramEvidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycationGlycation gap is associated with macroproteinuria but not with other complications in patients with type 2 diabetes.Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c.Cardiovascular disease, neuropathy, and retinopathy.Association of glycation gap with mortality and vascular complications in diabetes.Clinically significant disagreement between mean blood glucose and estimated average glucose in two populations: implications for diabetes management.Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications.Do race and ethnicity impact hemoglobin A1c independent of glycemia?Effect of ethnicity on HbA1c levels in individuals without diabetes: Systematic review and meta-analysisReview of hemoglobin A(1c) in the management of diabetes.Current controversies in the use of haemoglobin A1c.Biological variation and hemoglobin A1c: relevance to diabetes management and complications.Glycated Hemoglobin, Plasma Glucose, and Erythrocyte Aging.HbA1c for the diagnosis of diabetes and prediabetes: is it time for a mid-course correction?The heritability of HbA1c and fasting blood glucose in different measurement settings.Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring.Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction.Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.Hemoglobin glycation rate constant in non-diabetic Individuals.Relative contributions of preprandial and postprandial glucose exposures, glycemic variability, and non-glycemic factors to HbA 1c in individuals with and without diabetes.
P2860
Q24534263-73032F6F-813D-4664-A97E-E4CC08613834Q30360577-F2397A44-FB7A-4AF4-B1E8-38CA29536B81Q33584606-7C7834F8-1F9A-448D-9D62-AFC29618F66EQ33602143-FF8C384E-5BD2-482B-9086-CCABE3868D9BQ33804588-7929C7B1-BA97-4AA9-A8C9-7EC5A35CE199Q33932621-C3B4914F-F3CD-453E-9BC1-08E3C9909BC7Q34720652-F92DBD8B-63B9-4018-B67F-F248892D1A8AQ35123412-6E6B23B1-8CFA-4A72-8872-E0EBC498BBA8Q35390039-65F16984-2E65-4A81-A968-2EDA47278990Q35630701-6C03657F-4619-4B19-B263-D39C62624C66Q35812833-0973CD03-5CFD-4488-84F7-B0AD3FCF46CEQ35819187-C52C712B-107C-4C4C-B902-D0CA515E744AQ35841172-01E03B87-ECF1-470E-B6CA-53C64B093BC3Q36426671-5E9F1A4D-B09C-4DCB-AD48-68039522CA67Q36426844-0112E790-F7DE-4826-B388-54860CDEA7A7Q36640346-F1863023-3C12-4AAD-AE73-8EA01769883CQ36842619-B77814E3-E184-44FE-A9A4-E337C457B5EBQ36942120-CAA2C598-8445-42D5-88DC-29F55BA54765Q36969806-861971D7-BBCA-4496-AE0D-1EDD8224D8F7Q37189205-2F645DBD-398C-462C-85D2-6FE5B9F2B4CCQ37193623-2A741B3C-97D4-4036-AFFD-E504E2ACEB13Q37404475-63B54594-F6F5-499D-8675-2C5B0E3A97ADQ37404625-F694EDCC-0A65-4F8D-8D5F-7688E3493DB4Q37404631-79151DE9-A969-48E5-B1E8-DB95DA834490Q37638849-51A75118-216A-403C-850C-4B3C69317F3FQ37798056-DD3D2C1B-4056-409F-BB51-007DE7932392Q37983923-5A5F75A0-904C-4EA6-9D43-11685A15D8D7Q38129464-C7330C6C-79C8-49F1-8C29-77BCCFC42CECQ39597310-CCF8FFE8-C777-48FD-AD51-0B18DD4F1807Q42331648-CC61CE78-48F3-4831-B4DD-F7D040B695C8Q46240290-3639B27B-F32B-4986-8218-97F0B8C59E0FQ47134712-75E7ED69-1F65-47DB-A8DF-9B4EE588EE33Q47148809-B69FA94C-B523-4049-A267-4422AB39AF7CQ47199486-002F0F1F-4BDA-40B4-A529-E3C476A2E606Q50528671-26E39540-7ED9-4445-8699-8F0A960D7229Q55108599-AB82853A-C677-4B3B-BA8E-50C12B917F8B
P2860
Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Investigation of the mechanism ...... ects not related to glycaemia.
@en
Investigation of the mechanism ...... ects not related to glycaemia.
@nl
type
label
Investigation of the mechanism ...... ects not related to glycaemia.
@en
Investigation of the mechanism ...... ects not related to glycaemia.
@nl
prefLabel
Investigation of the mechanism ...... ects not related to glycaemia.
@en
Investigation of the mechanism ...... ects not related to glycaemia.
@nl
P2093
P1433
P1476
Investigation of the mechanism ...... ects not related to glycaemia.
@en
P2093
P356
10.1016/S0009-8981(96)06508-4
P577
1997-04-01T00:00:00Z